AAAAAA
Results:
1-20
|
Results: 20
Authors:
Pol, E
Bjork, I
Citation: E. Pol et I. Bjork, Role of the single cysteine residue, Cys 3, of human and bovine cystatin B(stefin B) in the inhibition of cysteine proteinases, PROTEIN SCI, 10(9), 2001, pp. 1729-1738
Authors:
Arocas, V
Bock, SC
Raja, S
Olson, ST
Bjork, I
Citation: V. Arocas et al., Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding, J BIOL CHEM, 276(47), 2001, pp. 43809-43817
Authors:
Larsson, H
Akerud, P
Nordling, K
Raub-Segall, E
Claesson-Welsh, L
Bjork, I
Citation: H. Larsson et al., A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity, J BIOL CHEM, 276(15), 2001, pp. 11996-12002
Authors:
Olsson, SL
Pihlgren, U
Ploen, L
Bjork, I
Citation: Sl. Olsson et al., Tissue distribution of bovine cystatin C analysed by in situ hybridisation, EUR J HIST, 44(2), 2000, pp. 171-178
Authors:
Estrada, S
Olson, ST
Raub-Segall, E
Bjork, I
Citation: S. Estrada et al., The N-terminal region of cystatin A (stefin A) binds to papain subsequent to the two hairpin loops of the inhibitor. Demonstration of two-step binding by rapid-kinetic studies of cystatin A labeled at the N-terminus with a fluorescent reporter group, PROTEIN SCI, 9(11), 2000, pp. 2218-2224
Authors:
Desai, U
Swanson, R
Bock, SC
Bjork, I
Olson, ST
Citation: U. Desai et al., Role of arginine 129 in heparin binding and activation of antithrombin, J BIOL CHEM, 275(25), 2000, pp. 18976-18984
Authors:
Pavlova, A
Krupa, JC
Mort, JS
Abrahamson, M
Bjork, I
Citation: A. Pavlova et al., Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutationof His110, FEBS LETTER, 487(2), 2000, pp. 156-160
Authors:
Stoka, V
Turk, B
McKerrow, JH
Bjork, I
Cazzulo, JJ
Turk, V
Citation: V. Stoka et al., The high stability of cruzipain against pH-induced inactivation is not dependent on its C-terminal domain, FEBS LETTER, 469(1), 2000, pp. 29-32
Authors:
Larsson, H
Sjoblom, T
Dixelius, J
Ostman, A
Ylinenjarvi, K
Bjork, I
Claesson-Welsh, L
Citation: H. Larsson et al., Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells, CANCER RES, 60(23), 2000, pp. 6723-6729
Wild-type and Met-65 -> Leu variants of human cystatin A are functionally and structurally identical
Authors:
Craven, CJ
Baxter, NJ
Murray, EH
Hill, NJ
Martin, JR
Ylinenjarvi, K
Bjork, I
Waltho, JP
Murray, IA
Citation: Cj. Craven et al., Wild-type and Met-65 -> Leu variants of human cystatin A are functionally and structurally identical, BIOCHEM, 39(51), 2000, pp. 15783-15790
Authors:
Arocas, V
Turk, B
Bock, SC
Olson, ST
Bjork, I
Citation: V. Arocas et al., The region of antithrombin interacting with full-length heparin chains outside the high-affinity pentasaccharide sequence extends to Lys136 but not to Lys139, BIOCHEM, 39(29), 2000, pp. 8512-8518
Authors:
Rong, JH
Nordling, K
Bjork, I
Lindahl, U
Citation: Jh. Rong et al., A novel strategy to generate biologically active neo-glycosaminoglycan conjugates, GLYCOBIOLOG, 9(12), 1999, pp. 1331-1336
Authors:
Olsson, SL
Ek, B
Bjork, I
Citation: Sl. Olsson et al., The affinity and kinetics of inhibition of cysteine proteinases by intact recombinant bovine cystatin C, BBA-PROT ST, 1432(1), 1999, pp. 73-81
Authors:
Ylinenjarvi, K
Widersten, M
Bjork, I
Citation: K. Ylinenjarvi et al., Hydrophobic sequences can substitute for the wild-type N-terminal sequenceof cystatin A (stefin A) in tight binding to cysteine proteinases - Selection of high-affinity N-terminal region variants by phage display, EUR J BIOCH, 261(3), 1999, pp. 682-688
Authors:
Valcarce, C
Bjork, I
Stenflo, J
Citation: C. Valcarce et al., The epidermal growth factor precursor - A calcium-binding, beta-hydroxyasparagine containing modular protein present on the surface of platelets, EUR J BIOCH, 260(1), 1999, pp. 200-207
Authors:
Turk, B
Dolenc, I
Lenarcic, B
Krizaj, I
Turk, V
Bieth, JG
Bjork, I
Citation: B. Turk et al., Acidic pH as a physiological regulator of human cathepsin L activity, EUR J BIOCH, 259(3), 1999, pp. 926-932
Authors:
Pol, E
Bjork, I
Citation: E. Pol et I. Bjork, Importance of the second binding loop and the C-terminal end of cystatin B(stefin B) for inhibition of cysteine proteinases, BIOCHEM, 38(32), 1999, pp. 10519-10526
Authors:
Arocas, V
Bock, SC
Olson, ST
Bjork, I
Citation: V. Arocas et al., The role of Arg46 and Arg47 of antithrombin in heparin binding, BIOCHEM, 38(31), 1999, pp. 10196-10204
Authors:
Turk, B
Awad, R
Usova, EV
Bjork, I
Eriksson, S
Citation: B. Turk et al., A pre-steady-state kinetic analysis of substrate binding to human recombinant deoxycytidine kinase: A model for nucleoside kinase action, BIOCHEM, 38(26), 1999, pp. 8555-8561
Authors:
Estrada, S
Pavlova, A
Bjork, I
Citation: S. Estrada et al., The contribution of N-terminal region residues of cystatin A (stefin A) tothe affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L, BIOCHEM, 38(22), 1999, pp. 7339-7345
Risultati:
1-20
|